Provided by Tiger Trade Technology Pte. Ltd.

Invivyd, Inc.

0.8053
-0.0247-2.98%
Post-market: 0.80530.00000.00%16:04 EDT
Volume:3.57M
Turnover:2.92M
Market Cap:237.56M
PE:-2.21
High:0.8400
Open:0.8300
Low:0.8007
Close:0.8300
52wk High:3.07
52wk Low:0.5277
Shares:295.00M
Float Shares:208.00M
Volume Ratio:1.10
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3641
EPS(LYR):-0.3048
ROE:-95.89%
ROA:-45.67%
PB:1.31
PE(LYR):-2.64

Loading ...

Invivyd Price Target Maintained with a $10.00/Share by BTIG

Dow Jones
·
Sep 14

Q32 Bio Names José Trevejo Chief Medical Officer

Reuters
·
Sep 14

Invivyd Grants New-Hire Inducement Stock Options for 255,000 Shares at $0.88 Each

Reuters
·
Sep 03

Invivyd Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 03

Invivyd Files Form 3 for Director Ian Sheffield`

Reuters
·
Sep 03

Cantor says Invivyd should be trading ‘meaningfully higher’ after update

TIPRANKS
·
Sep 01

Invivyd Names Chairman Marc Elia as CEO

MT Newswires Live
·
Sep 01

Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of Vyd2311 Studies Declaration and Liberty

THOMSON REUTERS
·
Sep 01

Invivyd, - Vyd2311 Declaration and Liberty Studies Approaching Completion with Updates Expected Within Weeks

THOMSON REUTERS
·
Sep 01

Invivyd, - Ajay Royan Appointed Lead Independent Director at Invivyd

THOMSON REUTERS
·
Sep 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)

TIPRANKS
·
Sep 01

Invivyd Price Target Maintained with a $10.00/Share by Cantor Fitzgerald

Dow Jones
·
Aug 27

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD), Traws Pharma (TRAW) and DocGo (DCGO)

TIPRANKS
·
Aug 18

Invivyd’s Nasdaq Listing at Risk: Potential Delisting Threatens Financing Access and Market Value

TIPRANKS
·
Aug 15

Invivyd (IVVD) Gets a Buy from Cantor Fitzgerald

TIPRANKS
·
Aug 14

Invivyd, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Invivyd Q2 EPS $(0.14) Misses $(0.11) Estimate, Sales $14.285M Miss $14.400M Estimate

Benzinga Earnings
·
Aug 14

Invivyd Q2 EPS USD -0.14

Reuters
·
Aug 14

Press Release: Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Dow Jones
·
Aug 14

Invivyd, Inc. Expected to Post a Loss of 11 Cents a Share - Earnings Preview

Reuters
·
Aug 10